Background: It is unknown whether patients with PD are at greater risk of COVID-19, what their risk factors are, and whether their clinical manifestations differ from the general population.
Objectives: The study aimed to address all these issues.
Want to read more?
Log in or sign up to access all Neurodiem content.
Already have an account? Log In
© 2020 International Parkinson and Movement Disorder Society